Clinical Trial Update: Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala [Phase 2]

View source ↗

Summary

Phase II trial of temozolomide for retinoblastoma metastatic to the central nervous system in patients from Guatemala was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Stanford University | Conditions: Retinoblastoma | Phase 2 | Status: TERMINATED